4.7 Article

Atypical pneumonia caused by Chlamydia psittaci during the COVID-19 pandemic

期刊

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
卷 122, 期 -, 页码 622-627

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2022.07.027

关键词

Psittacosis; mNGS; COVID-19; Atypical pneumonia; Chlamydia psittaci

向作者/读者索取更多资源

This study retrospectively described the diagnosis and treatment of 32 cases of Chlamydia psittaci pneumonia during the COVID-19 pandemic. It suggests that human psittacosis may be underdiagnosed and misdiagnosed clinically, especially during the COVID-19 pandemic. The use of metagenomic next-generation sequencing (mNGS) can be a rapid and accurate method for detecting suspected pathogens.
Objectives: Here, we retrospectively described the diagnosis and treatment of 32 cases diagnosed with Chlamydia psittaci pneumonia during the COVID-19 pandemic. Methods: Clinical information was collected from all the patients. Reverse transcription-PCR and ELISAs were conducted for the detection of COVID-19 using nasal swabs and bronchoalveolar lavage fluid (BALF) samples. Metagenomic next-generation sequencing (mNGS) was performed for the identification of causative pathogens using BALF, peripheral blood and sputum samples. End-point PCR was performed to confirm the mNGS results. Results: All 32 patients showed atypical pneumonia and had infection-like symptoms that were similar to COVID-19. Results of reverse transcription-PCR and ELISAs ruled out COVID-19 infection. mNGS identified C. psittaci as the suspected pathogen in these patients within 48 hours, which was validated by PCR, except for three blood samples. The sequence reads that covered fragments of C. psittaci genome were detected more often in BALF than in sputum or blood samples. All patients received doxycycline-based treatment regimens and showed favorable outcomes. Conclusion: This retrospective study, with the highest number of C. psittaci pneumonia enrolled cases in China so far, suggests that human psittacosis may be underdiagnosed and misdiagnosed clinically, especially in the midst of the COVID-19 pandemic. (c) 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据